Anaesthetic drugs: Linking molecular actions to clinical effects

Keyphrases

• GABAA Receptor (GABAAR) 100%
• Anesthetic Drugs 100%
• Clinical Effect 100%
• Molecular Action 100%
• Anesthetics 50%
• Immobility 50%
• Central Nervous System 33%
• Analgesia 33%
• General Anesthetics 33%
• Hypnosis 33%
• Intravenous Anesthetics 33%
• Volatile Anesthetics 33%
• Molecular Targets 16%
• Clinical Application 16%
• Glutamate Receptors 16%
• N-methyl-D-aspartate Receptor (NMDAR) 16%
• Knock 16%
• Knock-in Mouse Model 16%
• Anatomical Location 16%
• Spinal Cord 16%
• Potassium Channel 16%
• Nitrous Oxide 16%
• Route of Administration 16%
• Elderly Patients 16%
• General Anesthesia 16%
• Genetic Approach 16%
• Clinically Relevant Concentrations 16%
• Amnesia 16%
• Glycine Receptor 16%
• Sedation 16%
• Newborn Infant 16%
• Anesthetic Agents 16%
• Hypothermia 16%
• Ketamine 16%
• Side Effect Profile 16%
• Respiratory Depression 16%
• Multiple Molecular Targets 16%
• Ambulatory Surgery 16%

Medicine and Dentistry

• GABAA Receptor 100%
• Immobility 50%
• Receptor 33%
• Central Nervous System 33%
• Side Effect 33%
• Analgesia 33%
• Inhalation Anesthetic Agent 33%
• Neonatal Infant 16%
• Knock Out 16%
• General Anesthesia 16%
• Hypothermia 16%
• Anesthetic Agent 16%
• Lacunar Amnesia 16%
• Glycine Receptor 16%
• Ketamine 16%
• Potassium Channel 16%
• Elderly Patient 16%
• Ambulatory Surgery 16%
• Intravenous Anesthetic Agent 16%
• NMDA Receptor 16%
• Glutamate Receptor 16%
• Respiration Depression 16%
• Nitrous Oxide 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Immobility 37%
• Side Effect 25%
• Molecular Target 25%
• Inhalation Anesthetic Agent 25%
• Route of Administration 12%
• Potassium Channel 12%
• Hypothermia 12%
• Glycine Receptor 12%
• Anesthetic Agent 12%
• N Methyl Dextro Aspartic Acid Receptor 12%
• Ketamine 12%
• Respiration Depression 12%
• Nitrous Oxide 12%
• Glutamate Receptor 12%
• Intravenous Anesthetic Agent 12%